Sp. Blatt et al., LEGIONNAIRES-DISEASE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - 8 CASES AND REVIEW, Clinical infectious diseases, 18(2), 1994, pp. 227-232
Despite being a well-known pathogen for immunocompromised patients, Le
gionella pneumophila has infrequently been described in persons with i
nfection due to human immunodeficiency virus (HIV). Since 1986, we hav
e identified eight cases of legionella pneumonia among seven HIV-infec
ted persons enrolled in the HIV Natural History Study of the U.S. Air
Force. The median CD4(+) T cell count for these patients was 83/mm(3);
50% of the cases occurred in persons for whom AIDS was previously dia
gnosed, and five of the cases were nosocomial. Six of the patients had
coexistent pulmonary infections. None of the cases occurred among per
sons receiving prophylactic therapy with trimethoprim-sulfamethoxazole
. Therapeutically, all patients appeared to respond well to standard a
ntilegionella therapy or high doses of trimethoprim-sulfamethoxazole.
Overall, these seven patients represent 1.7% of the patients with late
-stage HIV infection (Waiter Reed stage 5 or 6) in this cohort. L. pne
umophila, although remaining an uncommon pathogen for HIV-infected pat
ients, may produce serious disease in this population. HIV-infected pe
rsons should be considered at risk for legionnaires' disease, particul
arly in institutions where potable water supplies have become contamin
ated.